Search

Policy on double awarding

We want to support as many young investigators and clinicians as possible in their career development. For this reason, we do not allow ‘double awarding.

Read more

Policy on double awarding

We want to support as many young investigators and clinicians as possible in their career development. For this reason, we do not allow ‘double awarding.

Read more

Policy on double awarding

We want to support as many young investigators and clinicians as possible in their career development. For this reason, we do not allow ‘double awarding.

Read more

Policy on double awarding

We want to support as many young investigators and clinicians as possible in their career development. For this reason, we do not allow ‘double awarding.

Read more

Selection panel and principles

Selection panel
EHA Board — Margarita Guenova
EHA Board — Jose Maria Ribera
Community and Stakeholder Committee — Darko Antic
Diversity, Equity, and Inclusion Taskforce — Mihnea-Alexandru Gaman
Education Committee — Jose Tomás Navarro Ferrando
European Affairs Committee — Julio Delgado
Patient Advocacy Committee — Derek Elston
Research…

Read more

Restoring Effective Anti-Tumor Response in Hodgkin Lymphoma with Nivolumab

Hodgkin Lymphoma typically affects young men and women in their 30s. Although it is highly curable with the current combination of chemo and radiation therapy, approximately 20% of patients will not be cured with first line regimens.

Read more

How to apply for CBTH

TimelinesApplication CBTH 2025
Deadline: September 24, 2024 (15:00 CEST)

Notification
November 2024

How to apply?Download the signature letter template. Fill in the template and get it duly signed for upload into the online application platform.

Read more

Abstract & Clinical Case Submission and Travel Grant

Abstract and clinical case procedureAbstract submission is closed

The official abstract submission closed on August 1, 2023 (23:59).

Read more